Aslaner Hümeyra, Aslaner Hacı Ahmet, Gökçek Mebrure Beyza, Benli Ali Ramazan, Yıldız Orhan
Kayseri City Hospital, Family Medicine, Kayseri, Turkey.
İncesu County State Hospital, Internal Medicine, Kayseri, Turkey.
Iran J Public Health. 2021 Apr;50(4):721-727. doi: 10.18502/ijph.v50i4.5996.
We aimed to reveal how chronic diseases, age and gender affected morbidity and mortality in patients with Coronavirus disease of 2019 (COVID-19).
Medical records of all reverse transcription polymerase chain reaction (RT-PCR) positive COVID-19 patients followed up in hospital and home isolation between 13 of Mar 2020 and 12 of May 2020 were retrospectively reviewed. The patients were from Kayseri Province, Turkey. Patients' demographic and clinical characteristics and the factors associated with morbidity and mortality were analyzed.
Of all the patients, 773 (95.8%) were alive and 34 (4.24%) died. The fatality rate was 4.2%. There were differences between the age groups in terms of fatality rate (<0.001). The fatality rate in patients above the age of 65 yr was significantly higher. The fatality rate in the male gender was 2.44 times higher (<0.05). It was 1.104 times higher in advanced age (<0.001) and 10.893 times higher in patients with at least one comorbid disease (<0.05). Hypertension increased mortality by 3.635 times (<0.05) and chronic pulmonary diseases by 2.926 times (<0.05).
Advanced age, male gender and accompanying chronic diseases have adverse effects on the course and severity of the disease and hospitalization. They also increased the rate and risk of mortality.
我们旨在揭示慢性病、年龄和性别如何影响2019冠状病毒病(COVID-19)患者的发病率和死亡率。
回顾性分析了2020年3月13日至2020年5月12日期间在医院接受随访及居家隔离的所有逆转录聚合酶链反应(RT-PCR)阳性COVID-19患者的病历。这些患者来自土耳其开塞利省。分析了患者的人口统计学和临床特征以及与发病率和死亡率相关的因素。
所有患者中,773例(95.8%)存活,34例(4.24%)死亡。病死率为4.2%。各年龄组的病死率存在差异(<0.001)。65岁以上患者的病死率显著更高。男性的病死率高2.44倍(<0.05)。高龄患者的病死率高1.104倍(<0.001),至少有一种合并症的患者病死率高10.893倍(<0.05)。高血压使死亡率增加3.635倍(<0.05),慢性肺部疾病使死亡率增加2.926倍(<0.05)。
高龄、男性以及伴随的慢性病对疾病的进程、严重程度和住院情况有不利影响。它们还增加了死亡率和死亡风险。